Skip to content

RADIENT PHARMACEUTICALS Corp

Delisted

CIK 838879fmd_0PCGM847R954X55P79966DSV60Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2010 to Dec 31, 2011, 6 periods

Latest annual · FY2011

Millions
Gross profit
0
Operating income
(10)
Net income
(86)
Free cash flow
(6)

Latest quarter · Q4 FY2011

Millions
Gross profit
0
Operating income
(4)
Net income
(47)
Free cash flow
(1)
Open Financials

RADIENT PHARMACEUTICALS Corp financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2011FY2010ChangeSource
Gross profit$261,783$185,337+41.2%10-K/A 2012-07-09 · proof
Operating income-$10 million-$14.1 million10-K/A 2012-07-09 · proof
Net income-$86.2 million-$85.7 million10-K/A 2012-07-09 · proof
Cash from operating activities-$5.7 million-$7.1 million10-K/A 2012-07-09 · proof
Free cash flow-$5.7 million-$7.1 million10-K/A 2012-07-09 · proof
Total assets$1.2 million$856,960+37.2%10-K/A 2012-07-09 · proof
Total liabilities$50.9 million$53.8 million-5.4%10-K/A 2012-07-09 · proof
Cash and cash equivalents$196,657$53,381+268.4%10-K/A 2012-07-09 · proof
What was RADIENT PHARMACEUTICALS Corp's gross profit in fiscal 2011?
RADIENT PHARMACEUTICALS Corp reported gross profit of $261,783 for fiscal 2011 (the year ended Dec 31, 2011), against $185,337 the year before (+41.2%). Source: the 10-K/A filed with the SEC on Jul 9, 2012. SEC
What was RADIENT PHARMACEUTICALS Corp's operating income in fiscal 2011?
RADIENT PHARMACEUTICALS Corp reported operating income of -$10 million for fiscal 2011 (the year ended Dec 31, 2011), against -$14.1 million the year before. Source: the 10-K/A filed with the SEC on Jul 9, 2012. SEC
What was RADIENT PHARMACEUTICALS Corp's net income in fiscal 2011?
RADIENT PHARMACEUTICALS Corp reported net income of -$86.2 million for fiscal 2011 (the year ended Dec 31, 2011), against -$85.7 million the year before. Source: the 10-K/A filed with the SEC on Jul 9, 2012. SEC
What was RADIENT PHARMACEUTICALS Corp's cash from operating activities in fiscal 2011?
RADIENT PHARMACEUTICALS Corp reported cash from operating activities of -$5.7 million for fiscal 2011 (the year ended Dec 31, 2011), against -$7.1 million the year before. Source: the 10-K/A filed with the SEC on Jul 9, 2012. SEC
What was RADIENT PHARMACEUTICALS Corp's free cash flow in fiscal 2011?
RADIENT PHARMACEUTICALS Corp reported free cash flow of -$5.7 million for fiscal 2011 (the year ended Dec 31, 2011), against -$7.1 million the year before. Source: the 10-K/A filed with the SEC on Jul 9, 2012. SEC
What are RADIENT PHARMACEUTICALS Corp's total assets?
As of Dec 31, 2011, RADIENT PHARMACEUTICALS Corp reported total assets of $1.2 million, against $856,960 a year earlier (+37.2%). Source: the 10-K/A filed with the SEC on Jul 9, 2012. SEC
What are RADIENT PHARMACEUTICALS Corp's total liabilities?
As of Dec 31, 2011, RADIENT PHARMACEUTICALS Corp reported total liabilities of $50.9 million, against $53.8 million a year earlier (-5.4%). Source: the 10-K/A filed with the SEC on Jul 9, 2012. SEC
What are RADIENT PHARMACEUTICALS Corp's cash and cash equivalents?
As of Dec 31, 2011, RADIENT PHARMACEUTICALS Corp reported cash and cash equivalents of $196,657, against $53,381 a year earlier (+268.4%). Source: the 10-K/A filed with the SEC on Jul 9, 2012. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:838879&period_type=annual&limit=5"

Information only, not investment advice.